Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,481.60
(
0.35%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
108.35
(
1.20%
)
Bitcoin
68,680.56
(
-0.26%
)
News Focus
News Focus
Post# of 1048
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mishe

Send PM Follow Ignore
Followers 0
Posts 36
Boards Moderated 0
Alias Born 12/09/2020

mishe

Re: None

Tuesday, 11/16/2021 9:20:30 AM

Tuesday, November 16, 2021 9:20:30 AM

Post# of 1048
$OTLC: Oncotelic Announces Successful Completion of Safety Evaluation of First Cohort in OT-101/IL-2 Combination Trial for Treatment of Solid Tumor Cancers: https://oncotelic.irpass.com/Oncotelic-Announces-Successful-Completion-of-the-Safety-Evaluation-of-a-TGF-946--Inhibitor--OT-101--and-IL-2--Aldesleukin--in-Phase-1-Combination-Trial-in-Solid-Tumor-Cancers-11-16-2021
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent OTLC News
More OTLC News